Alternative Schedule Sunitinib in Metastatic Renal Cell Carcinoma: Cardiopulmonary Exercise Testing

NCT03109015 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

7

Enrollment

OTHER

Sponsor class

Conditions

Carcinoma, Renal Cell

Interventions

DRUG: Sunitinib
DRUG: Sunitinib

Sponsor

Duke University